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ABSTRACT: The purpose of this meta-analysis is to review studies investigating the
efficacy of inspiratory muscle training (IMT) in chronic obstructive pulmonary disease
(COPD) patients and to find out whether patient characteristics influence the efficacy of
IMT.
A systematic literature search was performed using the Medline and Embase
databases. On the basis of a methodological framework, a critical review was
performed and summary effect-sizes were calculated by applying fixed and random
effects models.
Both IMT alone and IMT as adjunct to general exercise reconditioning significantly
increased inspiratory muscle strength and endurance. A significant effect was found for
dyspnoea at rest and during exercise. Improved functional exercise capacity tended to
be an additional effect of IMT alone and as an adjunct to general exercise
reconditioning, but this trend did not reach statistical significance. No significant
correlations were found for training effects with patient characteristics. However,
subgroup analysis in IMT plus exercise training revealed that patients with inspiratory
muscle weakness improved significantly more compared to patients without inspiratory
muscle weakness.
From this review it is concluded that inspiratory muscle training is an important
addition to a pulmonary rehabilitation programme directed at chronic obstructive
pulmonary disease patients with inspiratory muscle weakness. The effect on exercise
performance is still to be determined.
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In their meta-analysis, SMITH et al. [1] concluded
that inspiratory muscle training (IMT) in patients
with chronic obstructive pulmonary disease (COPD)
did not reveal significant treatment effects. However,
in a subsequent sensitivity analysis, they found a
significant difference in inspiratory muscle strength
(maximum static inspiratory alveolar pressure
(PI,max)) and dyspnoea in treatment groups in which
training loads were controlled compared to an
uncontrolled condition. They postulated that when
the training loads are controlled, increment in
inspiratory muscle strength and endurance might be
translated into a clinically meaningful improvement in
functional status.
Over the past 8 yrs, new studies in which training
loads were controlled have been performed to reveal
the efficacy of IMT. Most of these studies were
discussed in two extended reviews on the efficacy of
pulmonary rehabilitation [2, 3]. However, unlike that
of SMITH et al. [1], these reviews did not employ a
meta-analysis of the included studies. Both reviews
concluded that despite the adjusted training strategy,
the clinical relevance of IMT is still equivocal. In
addition, it was suggested that the choice of outcome
measures and methodological quality might influence
the efficacy of IMT [2, 3].
Besides differences in training strategy and metho-
dological quality, patient characteristics, such as
degree of hyperinflation, severity of airway obstruc-
tion and respiratory muscle weakness, might also
influence the efficacy of IMT.
The purpose of the present study is to provide an
update on the efficacy of IMT through a meta-
analysis of studies evaluating the efficacy of IMT in
patients with COPD. Special attention will be given to
patient characteristics that may influence the efficacy
of IMT, in order to select the appropriate patients
with COPD for the application of IMT.
Methods
Study identification and selection
The databases used for selection of the literature
were Medline (from 1966 to December 2000), Em-
base (from 1988 to December 2000), and relevant
Eur Respir J 2002; 20: 570–576
DOI: 10.1183/09031936.02.00237402
Printed in UK – all rights reserved
Copyright #ERS Journals Ltd 2002
European Respiratory Journal
ISSN 0903-1936
references from peer reviewed articles. The keywords
used in the literature search were: 1) respiratory
muscles and synonyms; 2) COPD, chronic airflow
limitation (CAL) or chronic airflow obstruction
(CAO); 3) exercise or training; and 4) human.
Literature was screened on title and/or abstract
contents. Articles not written in English, Dutch or
German were excluded. Studies also had to meet the
following criteria. 1) The study must have involved a
true experimentation (i.e. randomised controlled
trial). 2) Only patients with COPD were studied. 3)
Patients in the treatment group received inspiratory
muscle training at an intensity of o30% PI,max [4, 5].
4) Pulmonary function tests must have been con-
ducted. 5) Outcomes were described in terms of PI,max
inspiratory muscle endurance, dyspnoea rating, 6- or
12-min walking distance (6- or 12MWD) and/or
heath-related quality of life.
Critical review
The methodological quality of each of the
included studies was evaluated by two independent
reviewers (F. Lo¨tters and B. van Tol) using a
modification of the framework for methodological
quality used by SMITH et al. [1] (table 1). Agreement
regarding each criterion was evaluated by weighted
Kappa statistic. Disagreements regarding method-
ological quality were resolved by discussion between
the reviewers. When disagreement persisted, a third
reviewer (R. Gooselink) made the final decision.
Meta-analysis
The effect-size of each individual study was
calculated by the difference between means of the
treatment group and the control group after treat-
ment, divided by the pooled SD of the post-treatment
outcome measure of the treatment and control group
[1, 6, 7]. The calculated effect-sizes were weighted
for sample size and subsequently summarised to
obtain a weighted summary effect-size (SES) [6, 7].
The homogeneity test statistic (Q-statistic) of
each set of effect-sizes was examined to determine
whether studies shared a common effect-size, the
variance of which could only be explained by
sampling error. If a significant heterogeneity between
individual effect-sizes was found, a random effects
model was applied [7, 8]. Outcomes of interest
included PI,max, inspiratory muscle endurance
(expressed in s or sustained % PI,max), functional
exercise capacity (6MWD or 12MWD), maximal
exercise capacity (oxygen consumption-peak, maximal
minute ventilation (V9E,max)), dyspnoea rating and
heath-related quality of life measures.
In order to control for the effects of possible
publication bias on calculated SESs, the Rosenthal9s
"File Drawer Method" was applied [9]. This method
calculates the number of studies needed to achieve a
p-value ofw0.05.
Sensitivity analysis
The influence of the methodological quality of
individual studies on SES was analysed through use
of a weighting factor for each study. This weighting
factor was calculated by dividing the quality score
of each study by the maximum feasible score of
40 points. Subgroup analysis was performed for
studies adding IMT to general exercise recondi-
tioning and to trace whether the specificity of the
training device (threshold loading or flow-resistive
loading) influences the efficacy of IMT.
To determine possible prognostic characteristics
of the effectiveness of IMT, Spearman rank corre-
lation coefficients were calculated for baseline values
(forced expiratory volume in one second (FEV1),
forced residual capacity (FRC), PI,max and carbon
dioxide tension in arterial blood (Pa,CO2)) and
Table 1. – Criteria for methodological quality#
Score
Randomisation
Randomisation procedure described 5
Randomisation procedure not
described (or unable to tell)
0
Similarity of groups
Age, sex, FEV1, PI,max, walking
distance
0–5
Co-intervention
Comparable frequency of visits
Comparable medication changes
Comparable number of intercurrent
illnesses
0–5}
Masking
Patient
Therapist
Researcher 0–5}
Outcome measures
Validity and/or reliability mentioned
or referred to
5
Validity and/or reliability not
mentioned or referred to
0
Compliance
Training was supervised 5
Home programme with reporting
diary and periodic control visit
4
Home programme with either diary
or periodic control visit
3
Compliance not measured
(or unable to tell)
0
Exercise regime
Adequate description of intensity,
duration and frequency in both
exercise and control group
5
No adequate description of intensity,
duration and frequency
0
Follow-up
90–100% follow-up 5
80–89% follow-up 3
v80% subjects accounted for 1
Cannot tell 0
FEV1: forced expiratory volume in one second; PI,max:
maximum static inspiratory alveolar pressure. #: total
score=40 points;
}: 5 for 3 out of 3, 4 for 2 out of 3, 3 for
1 out of 3 and 0 for 0 out of 3.
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improvements in inspiratory muscle strength and
endurance in the treatment group.
Results
Critical review
Fifty-seven studies were identified by the literature
search. After screening these studies through use of
the inclusion criteria, 15 studies were included in the
present meta-analysis [10–24]. From these studies, five
[10, 12–14, 17] had also been included in the meta-
analysis of SMITH et al. [1]. From the initial 57 studies,
20 did not fulfil the criteria of COPD, 18 were
not randomised controlled trails, 30 did not use a
training intensity of o30% PI,max, six did not employ
relevant pulmonary function tests, and in 12 studies
no relevant outcome measures were used with regard
to this meta-analysis.
The weighted Kappa on inter-observer agreement
for the validity criteria varied from 0.59–1 (median
0.79). The methodological quality score varied
from 12–31 (median 24) of the maximal feasible
score of 40 points. The main methodological short-
comings were lack of an adequate description of
randomisation procedure, no validity and reliability
data of the used outcome measures mentioned, and
absence of (double) blinding procedures.
The overall treatment group contained 200 subjects
and the control group 183. The main patient
characteristics of the overall treatment group were:
age 63¡7 (n=200), height 170¡8 cm (n=73), weight
70¡13 kg (n=97), body mass index 25¡4 (n=65), FEV1
43¡15% (n=171), FRC 148¡42% (n=148), PI,max
71¡21% (n=200), and Pa,CO2 41¡6 mmHg (n=148).
Pulmonary function variables were expressed in %
predicted using the normative data of QUANJER et al.
[25]. PI,max was normalised using normative data
from ROCHESTER and ARORA [26]. PI,max was assessed
with maximal inspiratory mouth pressures from
residual volume (%) [11, 12, 14, 15, 17, 18, 24] or
FRC (%) [10, 19–22]. In one study [23], the sniff
test was used to determine transdiaphragmatic pres-
sure as measurement of inspiratory muscle strength.
Meta-analysis
Table 2 shows the results of the overall analysis.
Significant SESs were found for inspiratory muscle
strength, endurance and dyspnoea. Functional exer-
cise capacity tended to be an additional effect of IMT,
but this did not reach statistical significance (p=0.11).
Meta-analysis was not performed on health-related
quality of life, since different outcome measures were
used [12, 16–18], which hampers interpretation of the
findings. DEKHUIJZEN et al. [12] used the SCL-90 and
activities of daily living (ADL) list and found a
significant improvement in both training and control
groups, whereas no significant differences were
observed between the groups. LARSON et al. [18]
found similar results using the chronic respiratory
disease questionnaire (CRQ)-dyspnoea scale and the
CRQ fatigue scale. In the other two studies, which
used the Sickness Impact Profile, no significant effect
on heath-related quality of life was found [16, 17].
None of the baseline values of pulmonary function,
inspiratory muscle strength and Pa,CO2 were signifi-
cantly related to improvements in inspiratory muscle
strength or inspiratory muscle endurance.
In the overall analysis, the homogeneity test statistic
(Q-statistic) was not significant for all outcomes
(table 2). This implies that effect-sizes were homo-
geneous between studies, when compared with the
variance within studies involved. After weighting for
Table 2. – Overall results of the meta-analysis using the fixed effect model
Outcome measure Studies
n
Weighted
averaged effect-size
Natural
units
95%
CI
Z-statistic Homogeneity
Q-statistic
Studies
needed# n
Inspiratory muscle
strength PI,max
15 0.56 10.5 cmH2O 0.35–0.77 5.27* 16.83 o77
Inspiratory muscle
endurance MVV
4 0.21 2.8 L?min-1 -0.29–0.70 0.82 1.38
Inspiratory muscle
endurance s
7 0.41 154.2 s 0.14–0.68 2.94** 6.67 o14
Inspiratory muscle
endurance cmH2O
4 1.16 10.3 cmH2O 0.67–0.15 4.67* 5.39 o10
Functional exercise
capacity 6- or
12MWD
8 0.22 48.1 m -0.05–0.48 1.58 2.58
Laboratory exercise
capacity V9O2,max
5 0.04 -0.04 L?min-1 -0.36–0.29 -0.24 2.50
Laboratory Exercise
capacity V9E,max
5 0.03 -1.5 L?min-1 -0.03–0.35 0.16 5.49
Dyspnea-Borg
exercise-related
5 -0.55 -1.5 -0.90–0.19 -3.10** 3.69 o10
Dyspnoea-TDI rest 2 2.3 2.7 1.44–3.15 5.28** 4.14 o14
CI: confidence interval; PI,max: maximum static inspiratory alveolar pressure; MVV: maximal voluntary ventilation; 6- or
12MWD: 6- or 12-min walking distance; V9O2,max: maximal oxygen consumption; V9E,max: maximal minute ventilation;
TDI: transitional dyspnoea index. #: studies needed for pw0.05; **: pv0.01; ***: pv0.001.
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differences in methodological quality, sensitivity
analysis showed almost identical SESs and concomi-
tant confidence intervals for all outcomes.
In the 15 studies included, two types of inspiratory
muscle loading were applied: targeted resistive train-
ing [10, 12, 14, 15, 20] and training with a threshold
loading device [11, 13, 16–19, 21–24]. Subgroup
analysis revealed that there were no differences in
the outcome of inspiratory muscle strength (Chi-
squared=0.009, p=0.93) and inspiratory muscle
endurance (Chi-squared=0.36, p=0.55) regarding the
different types of training.
Inspiratory muscle training as an adjunct to general
exercise reconditioning
The subgroup analysis of studies adding IMT to
general exercise reconditioning revealed significantly
weighted SESs of inspiratory muscle strength and
endurance (table 3). No additional effect on func-
tional exercise capacity was observed (p=0.34). Due
to the significantly heterogeneous outcome for inspira-
tory muscle strength (Chi-squared=13.28, pv0.05), a
subgroup analysis was conducted. The six studies were
divided into studies with inspiratory muscle weakness
(indicated by a mean baseline PI,max¡60 cmH2O [27])
and one without inspiratory muscle weakness. In this
analysis, both subgroups showed homogeneity. The
two groups differed significantly in improvement in
inspiratory muscle strength (Chi-squared=8.81,
pv0.01). Inspiratory muscle strength improved sig-
nificantly in the group with inspiratory muscle
weakness (16 cmH2O, z=4.08, pv0.001), but not in
the group without inspiratory muscle weakness
(-3 cmH20, z=-0.61, p=0.54) (fig. 1a).
Because of the initial heterogeneity, the same
analysis was conducted using the random effect
model. There was an improvement in PI,max
(SES=0.45, confidence interval=-0.09–0.99) in this
analysis, but this did not reach statistical significance
because of the wide variance (z=1.63, p=0.10).
However, the subgroups still differed significantly
(Chi-squared=5.75, pv0.05) (table 4).
The mean weighted effect-size of functional exercise
capacity for the group with inspiratory muscle
weakness was 0.33 (z=1.17, p=0.24) and -0.02
Table 3. – Subgroup analysis of general exercise reconditioning plus inspiratory muscle training versus general exercise
reconditioning alone using the fixed-effect model
Outcome measure Studies
n
Weighted averaged
effect-size
Natural
units
95%
CI
Z-statistic Homogeneity
Q-statistic
Inspiratory muscle
strength PI,max
6 0.47 6.7 cmH2O 0.15–0.79 2.88** 13.28*
Inspiratory muscle
endurance MVV
2 -0.03 -0.95 L?min-1 -0.77–0.72 -0.07 0.14
Inspiratory muscle
endurance in s
3 0.55 164.4 s 0.14–0.97 2.61** 0.09
Functional exercise
capacity 6- or 12MWD
4 0.20 54 m -0.21–0.61 0.95 0.79
Laboratory exercise
capacity V9O2,max
3 -0.17 -0.01 L?min-1 -0.69–0.35 -0.63 0.16
Laboratory exercise
capacity V9E,max
3 -0.10 1.2 L?min-1 -0.61–0.42 -0.38 0.01
CI: confidence interval; PI,max: maximum static inspiratory alveolar pressure; MVV: maximal voluntary ventilation; 6- or 12MWD:
6- or 12-min walking distance; V9O2,max: maximal oxygen consumption; V9E,max: maximal minute ventilation. *: pv0.05; **: pv0.01.
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Fig. 1. – Weighted summary effect-sizes of a) inspiratory muscle
strength and b) functional exercise capacity (SD units) for the
studies with general exercise reconditioning plus inspiratory
muscle training. Subgroups were divided on the basis of their
baseline maximum static inspiratory alveolar pressue (PI,max)
(w60 cmH2O: without inspiratory muscle weakness; ¡60 cmH2O:
with inspiratory muscle weakness). The horizontal lines indicate
the 95% confidence intervals of the outcomes. The diamonds
indicate the weighted summary effect-sizes of the groups.
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(z=-0.06, p=0.95) for the group without inspiratory
muscle weakness (fig. 1b). This difference, however,
was not statistically significant, probably due to the
large variability in data.
Discussion
From the present meta-analysis it can be concluded
that IMT alone significantly improves inspiratory
muscle strength and endurance, whereas the sensation
of dyspnoea significantly decreases in patients with
COPD. No significant additional effects of IMT on
exercise performance were found. Patient character-
istics, such as hyperinflation and degree of severity,
and the training device used did not have any effect on
the efficacy of IMT. A subgroup analysis of IMT as
an adjunct to general exercise reconditioning revealed
that inspiratory muscle weakness appeared to play an
important role in the efficacy of IMT.
Potential errors in meta-analysis
Despite some shortcomings in study design, the
SESs of all outcomes did not change when metho-
dological quality was used as a weighting factor. A
potential problem of conducting a meta-analysis
might be the pooling of data from trials with different
patient characteristics. However, in the overall analy-
sis, the outcomes were homogeneous with respect to
patient characteristics, as indicated by the homogene-
ity test statistic (Q), justifying the application of a
fixed effects model. However, in the subgroup analysis
of IMT as an adjunct to general exercise recondition-
ing, the outcome of inspiratory muscle strength
appeared to be significantly heterogeneous, indicating
that the studies did not have a common population
effect-size regarding the outcome for inspiratory
muscle strength. Additional analysis revealed a
significant difference in outcome for inspiratory
muscle strength in studies that included patients
with inspiratory muscle weakness, as indicated by a
mean baseline PI,max of ¡60 cmH2O [12, 23, 24],
compared to those that included patients with no
inspiratory muscle weakness [11, 13, 18] (fig. 1a).
Further analysis of these subgroups indicates that
weakness of the inspiratory muscles might be an
important prognostic factor of the efficacy of IMT.
This finding further confirms that patient selection
plays a key role in the efficacy of IMT. Additional
analysis revealed thaty25 unpublished studies (range
10–77) with an average effect of zero are needed to
reverse the findings of the present study (table 2).
Efficacy of inspiratory muscle training alone
The findings of the present meta-analysis are in
contrast with the findings of SMITH et al. [1]. In their
meta-analysis, no significant effects of inspiratory
muscle strength, endurance and dyspnoea were
observed in the overall analysis. However, in their
meta-analysis only five out of 17 studies controlled for
training load, whereas in the present meta-analysis
controlling the training load was a feature in all
studies involved.
The result of an increasing PI,max and a conco-
mitant decrease in dyspnoea sensation corresponds
with the observed inverse relationship between
PI,max and dyspnoea [28–30]. This conclusion sup-
ports the suggestion in the joint American College
of Chest Physicians and American Association
of Cardiovascular and Pulmonary Rehabilitation
evidence-based guidelines that IMT might be con-
sidered in patients with decreased inspiratory muscle
strength and breathlessness [2].
No correlation was found between patient char-
acteristics and improvements in inspiratory muscle
strength and endurance when using Spearman rank
correlation coefficients. This finding is probably due
to the low number of studies (n¡15) in which the
Spearmean rank coefficients were calculated. Further-
more, the Spearman rank coefficients could only be
calculated by using the means of the variables of
whole studies and not individual patient data, which
may have masked a possible association between
effects and patient characteristics.
There is no evidence to support resistive or
threshold loading as the training method of choice.
Resistive breathing has the disadvantage that the
inspiratory pressure is flow dependent [10]. Threshold
loading has the advantage of being independent of
inspiratory flow rate [31]. However, it requires a
build up of negative pressure before flow occurs, and
hence, is inertive in nature. BELMAN et al. [32]
showed that similar work loads were obtained
during resistive loading and threshold loading.
Threshold loading enhances velocity of inspiratory
muscle contraction [22]. This is a favourable alteration
of the breathing pattern as it shortens inspira-
tory time and increases time for exhalation and
relaxation. Whether resistive loading or this inertive
Table 4. – Subgroup analysis of general exercise reconditioning plus inspiratory muscle training versus general exercise
reconditioning alone, for the outcome inspiratory muscle strength maximum static inspiratory alveolar pressure (PI,max)
using the random-effect model
Baseline values
PI,max
Studies
n
Weighted averaged
effect-size
Natural units 95% CI Z-statistic Q-between
Total group 6 0.45 6.7 cmH2O -0.09–0.99 1.63
Group 1 3 0.93 16 cmH2O 0.20–1.66 2.51** 5.75*
Group 2 3 -0.14 -3 cmH2O -0.95–0.67 -0.35
CI: confidence intervals. Group 1: PI,max¡60 cmH2O; Group 2: PI,maxw60 cmH2O. *: pv0.05; **: pv0.01.
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loading produces different training effects, remains to
be studied.
Efficacy of inspiratory muscle training as an adjunct
to general exercise reconditioning
From the present meta-analysis, IMT plus general
exercise reconditioning appeared to have strong
significant training effects on inspiratory muscle
strength and endurance, especially in patients with
inspiratory muscle weakness.
Only two studies from the subgroup analysis
measured exercise-related dyspnoea [11, 18]. Neither
study found a significant decrease in dyspnoea after
IMT, which was probably due to the high baseline
PI,max (79% [11] and 85–110% [18]), suggesting that
inspiratory muscle performance was probably not
the primary cause of dyspnoea in these patients.
Improvement in exercise performance in patients
with muscle weakness tended to be higher, but failed
to reach statistical significance. The small number of
studies involved in this subgroup analysis might
have affected this. However, the data from this
meta-analysis give some indication that IMT as an
adjunct to general exercise reconditioning has a
beneficial effect on functional exercise capacity in
patients with inspiratory muscle weakness.
Functional exercise capacity
Improved functional exercise capacity tended to
be an additional effect of IMT (alone and as an
adjunct to general exercise reconditioning), but this
trend did not reach statistical significance. This might
be due to the fact that ventilatory limitation during
exercise, indicated by a rising Pa,CO2 during exercise
[33] and/or an increase of the V9E/maximal voluntary
ventilation (MVV) ratio w70% during exercise [34],
was used as a selection criterion in only three of the
15 studies included [12, 18, 19]. These three studies
all found a significant increase in functional exercise
capacity after IMT as an adjunct to general exercise
reconditioning. The findings in the present meta-
analysis were supported by those in a recent study by
SCHERER et al. [35], in which a strong significant
increase in functional exercise capacity after IMT in a
group of COPD patients with ventilatory limitation
(V9E/MVV=85%) was found in favour of the treat-
ment group. However, it must be stated that the
training used in this study (normocapnic hyper-
pneu) differed from the training used in the studies
included in the current meta-analysis. A study by
SONNE and DAVIS [36] also showed that exercise
capacity was significantly increased after IMT in
patients with ventilatory limitation (V9E/MVVw80%)
[36]. Accordingly, it is possible that IMT in the other
studies was applied to patients in whom inspiratory
muscle performance was not the limiting factor of
exercise capacity. In the study by BERRY et al. [11],
no significant effect of IMT on exercise capacity was
found. This was probably due to the fact that
the treatment group was not ventilatorily limited
(V9E/MVV=51%) and had no inspiratory muscle
weakness (baseline PI,max 79% pred). In the study
by LARSON et al. [18], a ventilatory limitation was
found in the treatment group, but the baseline PI,max
was 85–110% pred, indicating that inspiratory mus-
cle weakness was not the primary cause of the venti-
latory limitation during exercise.
The small effect of IMT on functional exercise
capacity might also be explained by other physio-
logical factors, such as peripheral muscle weakness
[37], or limitations in blood flow directed to the
peripheral muscles and oxygen extraction during
general exercise reconditioning [38]. However, neither
of the included studies addressed this problem. For
a better understanding of the limitation that affects
functional exercise capacity, these factors have to be
considered in future research.
Conclusions and practical implications of the findings
IMT significantly increased inspiratory muscle
strength and inspiratory muscle endurance. In addi-
tion, a clinically significant decrease in dyspnoea
sensation at rest and during exercise was observed
after IMT.
Improved functional exercise capacity tended to
be an additional effect of IMT alone and of IMT as
an adjunct to general exercise reconditioning, but
this trend did not reach statistical significance. It
was therefore shown that inspiratory muscle weak-
ness (PI,max ¡60 cmH2O) plays a key role in the
efficacy of IMT. The role of ventilatory limitation on
the efficacy of IMT is still to be determined.
From the present meta-analysis it can be stated
that inspiratory muscle training is a meaningful
addition to pulmonary rehabilitation programmes
directed at chronic obstructive pulmonary disease
patients with inspiratory muscle weakness. Future
studies evaluating the efficacy of inspiratory muscle
training should select patients using these criterion.
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